China Universal Asset Management Co., Ltd. Bei Gene, Ltd. Transaction History
China Universal Asset Management Co., Ltd.
- $893 Million
- Q3 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Bei Gene, Ltd. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 8,510 shares of BGNE stock, worth $1.71 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
8,510
Previous 5,024
69.39%
Holding current value
$1.71 Million
Previous $716,000
166.76%
% of portfolio
0.21%
Previous 0.1%
Shares
14 transactions
Others Institutions Holding BGNE
# of Institutions
254Shares Held
45.3MCall Options Held
292KPut Options Held
119K-
Baker Bros. Advisors LP New York, NY10.6MShares$2.12 Billion25.41% of portfolio
-
Capital International Investors Los Angeles, CA6.43MShares$1.29 Billion0.29% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.18MShares$1.04 Billion26.65% of portfolio
-
Primecap Management CO Pasadena, CA4.97MShares$1 Billion0.84% of portfolio
-
Baillie Gifford & CO3.71MShares$745 Million0.64% of portfolio
About BeiGene, Ltd.
- Ticker BGNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,700,000
- Market Cap $20.8B
- Description
- BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...